Prevenar 20 (formerly Apexxnar) suspension for injection

*
Pharmacy Only: Prescription

Updated on 13 November 2024

File name

Adv SPC PE 6_0 IE clean.pdf

Reasons for updating

  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties

Legal category:Product subject to medical prescription which may not be renewed (A)

Free text change information supplied by the pharmaceutical company

The SPC has been updated as follows: Sections 5.1 and 5.2 to add conclusions from study 1027 and remove the information on paediatric deferral since all studies are now complete.

Updated on 13 March 2024

File name

Adv SPC PE 50 IE clean.pdf

Reasons for updating

  • Change to section 4.1 - Therapeutic indications
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 13 March 2024

File name

Adv PIL PE 50 IE NI clean.pdf

Reasons for updating

  • Change to section 1 - what the product is used for
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - how to take/use
  • Change to section 4 - possible side effects
  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision
  • Change to name of medicinal product
  • Change to information for healthcare professionals

Updated on 12 January 2023

File name

Adv SPC PE 4_0 IE clean.pdf

Reasons for updating

  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 12 January 2023

File name

Adv PIL PE 4_0 IE NI clean.pdf

Reasons for updating

  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision
  • Change to information for healthcare professionals

Updated on 10 November 2022

File name

Adv SPC PE 3_0 IE clean.pdf

Reasons for updating

  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 10 November 2022

File name

Adv PIL PE 3_0 IE NI clean.pdf

Reasons for updating

  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision
  • Change to information for healthcare professionals

Updated on 09 September 2022

File name

Adv SPC PE 2_0 IE clean.pdf

Reasons for updating

  • Change to section 6.5 - Nature and contents of container

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 09 September 2022

File name

Adv PIL PE 2_0 IE NI clean.pdf

Reasons for updating

  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision

Updated on 11 April 2022

File name

Adv SPC PE 1_0 IE.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 11 April 2022

File name

Adv PIL PE 1_0 IE NI.pdf

Reasons for updating

  • New PIL for new product